levetiracetam

Generic: levetiracetam

Labeler: preferred pharmaceuticals, inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name levetiracetam
Generic Name levetiracetam
Labeler preferred pharmaceuticals, inc.
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

levetiracetam 250 mg/1

Manufacturer
Preferred Pharmaceuticals, Inc.

Identifiers & Regulatory

Product NDC 68788-7884
Product ID 68788-7884_7e2c911d-dfb5-4dd0-ad7f-23a0a481fa4b
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090515
Listing Expiration 2026-12-31
Marketing Start 2021-03-29

Pharmacologic Class

Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 687887884
Hyphenated Format 68788-7884

Supplemental Identifiers

RxCUI
311288
UNII
44YRR34555
NUI
N0000008486

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name levetiracetam (source: ndc)
Generic Name levetiracetam (source: ndc)
Application Number ANDA090515 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 250 mg/1
source: ndc
Packaging
  • 100 TABLET, FILM COATED in 1 BOTTLE (68788-7884-1)
  • 20 TABLET, FILM COATED in 1 BOTTLE (68788-7884-2)
  • 30 TABLET, FILM COATED in 1 BOTTLE (68788-7884-3)
  • 60 TABLET, FILM COATED in 1 BOTTLE (68788-7884-6)
  • 90 TABLET, FILM COATED in 1 BOTTLE (68788-7884-9)
source: ndc

Packages (5)

Ingredients (1)

levetiracetam (250 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7e2c911d-dfb5-4dd0-ad7f-23a0a481fa4b", "openfda": {"nui": ["N0000008486"], "unii": ["44YRR34555"], "rxcui": ["311288"], "spl_set_id": ["419b3dba-ae21-4268-ac8b-342aaa609554"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Preferred Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, FILM COATED in 1 BOTTLE (68788-7884-1)", "package_ndc": "68788-7884-1", "marketing_start_date": "20210329"}, {"sample": false, "description": "20 TABLET, FILM COATED in 1 BOTTLE (68788-7884-2)", "package_ndc": "68788-7884-2", "marketing_start_date": "20210329"}, {"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (68788-7884-3)", "package_ndc": "68788-7884-3", "marketing_start_date": "20210329"}, {"sample": false, "description": "60 TABLET, FILM COATED in 1 BOTTLE (68788-7884-6)", "package_ndc": "68788-7884-6", "marketing_start_date": "20210329"}, {"sample": false, "description": "90 TABLET, FILM COATED in 1 BOTTLE (68788-7884-9)", "package_ndc": "68788-7884-9", "marketing_start_date": "20210329"}], "brand_name": "Levetiracetam", "product_id": "68788-7884_7e2c911d-dfb5-4dd0-ad7f-23a0a481fa4b", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "68788-7884", "generic_name": "Levetiracetam", "labeler_name": "Preferred Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "250 mg/1"}], "application_number": "ANDA090515", "marketing_category": "ANDA", "marketing_start_date": "20210329", "listing_expiration_date": "20261231"}